Monopar Therapeutics (MNPR) Net Income: 2017-2019
Historic Net Income for Monopar Therapeutics (MNPR) over the last 3 years, with Dec 2019 value amounting to -$1.2 million.
- Monopar Therapeutics' Net Income fell 32.23% to -$1.2 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$4.3 million, marking a year-over-year decrease of 36.88%. This contributed to the annual value of -$4.3 million for FY2019, which is 31.04% down from last year.
- Monopar Therapeutics' Net Income amounted to -$1.2 million in Q4 2019, which was down 61.29% from -$759,448 recorded in Q3 2019.
- In the past 5 years, Monopar Therapeutics' Net Income registered a high of -$373,839 during Q1 2017, and its lowest value of -$14.9 million during Q3 2017.
- In the last 3 years, Monopar Therapeutics' Net Income had a median value of -$828,354 in 2018 and averaged -$2.0 million.
- Over the last 5 years, Monopar Therapeutics' Net Income had its largest YoY gain of 95.52% in 2018, and its largest YoY loss of 140.01% in 2018.
- Monopar Therapeutics' Net Income (Quarterly) stood at -$736,800 in 2017, then decreased by 25.73% to -$926,358 in 2018, then tumbled by 32.23% to -$1.2 million in 2019.
- Its Net Income was -$1.2 million in Q4 2019, compared to -$759,448 in Q3 2019 and -$932,109 in Q2 2019.